Literature DB >> 1001976

Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.

G P van Berge Henegouwen, K H Brandt, H Eyssen, G Parmentier.   

Abstract

Samples of serum, bile, and urine were collected simultaneously from patients with cholestasis of varying aetiology and from patients with cirrhosis; their bile acid composition was determined by gas/liquid chromatography and mass spectrometry. In cholestasis, the patterns in all three body fluids differed consistently and strikingly. In serum, cholic acid was the major bile acid and most bile acids (greater than 93%) were unsulphated, whereas, in urine, chenodeoxycholic was the major bile acid, and the majority of bile acids (greater than 60%) were sulphated. Secondary bile acids were virtually absent in bile, serum, and urine. The total amount of bile acids excreted for 24 hours correlated highly with the concentration of serum bile acids; in patients with complete obstruction, urinary excretion averaged 71-6 mg/24 h. In cirrhotic patients, serum bile acids were less raised, and chenodeoxycholic acid was the predominant acid. In healthy controls, serum bile acids were consistently richer in chenodeoxycholic acid than biliary bile acids, and no bile acids were present in urine. No unusual monohydroxy bile acids were present in patients with primary biliary cirrhosis, but, in several patients, there was a considerable amount of hyocholic acid present in the urinary bile acids. The analyses of individual bile acids in serum and urine did not appear to provide helpful information in the differential diagnosis of cholestasis. Thus, in cholestasis, conjugation of chenodeoxycholic acid with sulphate becomes a major biochemical pathway, urine becomes a major route of bile acid excretion, and abnormal bile acids are formed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1001976      PMCID: PMC1411206          DOI: 10.1136/gut.17.11.861

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  IDENTIFICATION OF ALLODEOXYCHOLIC ACID AS THE MAJOR COMPONENT OF GALLSTONES INDUCED IN THE RABBIT BY 5-ALPHA-CHOLESTAN-3-BETA-OL.

Authors:  A F HOFMANN; E H MOSBACH
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

2.  MEASUREMENT OF HUMAN SERUM BILE ACIDS BY GAS-LIQUID CHROMATOGRAPHY.

Authors:  D H SANDBERG; J SJOEVALL; K SJOEVALL; D A TURNER
Journal:  J Lipid Res       Date:  1965-04       Impact factor: 5.922

3.  [Bile acids in the serum of patients with extrahepatic cholestasis with chronic liver diseases].

Authors:  W Erb; J Schreiber; M Walczak
Journal:  Z Gastroenterol       Date:  1973-05       Impact factor: 2.000

Review 4.  Nonsuppurative destructive chronic cholangitis and chronic hepatitis.

Authors:  H Popper; F Schaffner
Journal:  Prog Liver Dis       Date:  1970

5.  [Gaschromatography studies of serum bile acids: methods as well as results in patients with acute hepatitis].

Authors:  W Erb; W E Schreiber; M Walczak
Journal:  Z Gastroenterol       Date:  1972       Impact factor: 2.000

6.  Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.

Authors:  I Makino; S Nakagawa; K Mashimo
Journal:  Gastroenterology       Date:  1969-06       Impact factor: 22.682

7.  Presence of bile acids in jaundiced human urine.

Authors:  J A Gregg
Journal:  Nature       Date:  1967-04-01       Impact factor: 49.962

8.  Excretion of 3beta-hydroxy-5-cholenoic and 3a-hydroxy-5a-cholanoic acids in urine of infants with biliary atresia.

Authors:  I Makino; J Sjövall; A Norman; B Strandvik
Journal:  FEBS Lett       Date:  1971-06-10       Impact factor: 4.124

9.  Bile salt secretion in cirrhosis of the liver.

Authors:  L A Turnberg; G Grahame
Journal:  Gut       Date:  1970-02       Impact factor: 23.059

10.  Cholic acid synthesis as an index of the severity of liver disease in man.

Authors:  W C McCormick; C C Bell; L Swell; Z R Vlahcevic
Journal:  Gut       Date:  1973-11       Impact factor: 23.059

View more
  36 in total

1.  Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice.

Authors:  Xian Pan; Rebecca Kent; Kyoung-Jae Won; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2017-02-02       Impact factor: 3.922

2.  Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS.

Authors:  Yazen Alnouti; Iván L Csanaky; Curtis D Klaassen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-09-03       Impact factor: 3.205

Review 3.  Molecular mechanisms of cholestasis.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Wien Med Wochenschr       Date:  2006-07

Review 4.  Serum bile acids in hepatobiliary disease.

Authors:  I A Bouchier; C R Pennington
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

5.  The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.

Authors:  Kevin T Bush; Wei Wu; Christina Lun; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2017-08-01       Impact factor: 5.157

Review 6.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

7.  Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

Authors:  R A Jorgensen; E R Dickson; A F Hofmann; S S Rossi; K D Lindor
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

8.  Altered bile acid metabolism in primary biliary cirrhosis.

Authors:  R Raedsch; B H Lauterburg; A F Hofmann
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

9.  Bile acid conjugation in the chimpanzee: effective sulfation of lithocholic acid.

Authors:  M Schwenk; A F Hofmann; G L Carlson; J A Carter; F Coulston; H Greim
Journal:  Arch Toxicol       Date:  1978-04-27       Impact factor: 5.153

10.  Isolation of a bile salt sulfatase-producing Clostridium strain from rat intestinal microflora.

Authors:  S M Huijghebaert; J A Mertens; H J Eyssen
Journal:  Appl Environ Microbiol       Date:  1982-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.